Metabolic Health9 min read·Published October 3, 2026

What Causes Insulin Resistance? Risk Factors, Signs, and What Helps

Insulin resistance can be driven by weight, inactivity, genetics, sleep, hormones, medicines, and related conditions. Here is how clinicians think through it.

What Causes Insulin Resistance? Risk Factors, Signs, and What Helps

Insulin resistance happens when muscle, fat, and liver cells stop responding well to insulin, so the pancreas must make more insulin to move glucose out of the blood. Common drivers include excess abdominal fat, physical inactivity, genetics, age, poor sleep, smoking, some medicines, and conditions such as PCOS, sleep apnea, Cushing’s syndrome, and prediabetes 1, 2.

Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.

See if you qualify →

What does insulin resistance mean?

Insulin resistance means your cells do not respond to insulin as strongly as expected. In response, the pancreas may make more insulin, a state called hyperinsulinemia, to keep blood glucose in range 1, 2.

How insulin normally moves glucose into cells

After you eat, carbohydrates break down into glucose, which enters the blood. Insulin acts like a signal that helps glucose move into muscle, fat, and liver cells so it can be used or stored for energy 2.

What changes when cells become less sensitive to insulin

When cells become less sensitive, the pancreas has to work harder. For a while, extra insulin may keep glucose normal. Over time, blood glucose can rise, which is called hyperglycemia 1.

How insulin resistance can lead to prediabetes and type 2 diabetes

Prediabetes means blood glucose is higher than normal but not high enough for type 2 diabetes. Insulin resistance can raise the risk of prediabetes and type 2 diabetes, though not everyone with insulin resistance develops diabetes 1, 2. Type 1 diabetes is different: it is an autoimmune disease where the body makes little or no insulin 11.

What quick facts should you know about insulin resistance?

Insulin resistance often has no clear symptoms, so routine care focuses on risk factors and blood glucose testing. Risk can rise with abdominal weight gain, inactivity, family history of diabetes, age 35 or older, smoking, sleep apnea, PCOS, gestational diabetes history, and some medicines 1, 3.

  • Blood sugar tests can find prediabetes or diabetes, but routine direct testing for insulin resistance is not common in clinical care 1.
  • Acanthosis nigricans, which is darker, velvety skin in body folds, can be a clinical clue, but it is not proof by itself 1.
  • Lifestyle changes and weight loss, when appropriate, can improve insulin sensitivity and lower type 2 diabetes risk 2, 4.
  • If you already have diabetes, medication decisions should be made with a diabetes clinician, not from symptoms alone 3.

What causes insulin resistance in the body?

Insulin resistance usually has more than one cause. The main pattern is that cells are exposed to metabolic stress over time, especially when excess energy is stored in the liver, muscle, and abdominal fat 1, 2.

Excess energy storage and abdominal fat

Abdominal obesity and a large waist size are linked with insulin resistance. Fat stored around the organs can release signals that affect how the liver and muscles respond to insulin 1.

Physical inactivity and lower muscle glucose use

Muscle is a major place where glucose is used. When activity is low, muscles use less glucose, and insulin sensitivity can fall. Regular movement helps muscle cells take up glucose more effectively 2.

Genetics and family history

Family history matters. A parent or sibling with type 2 diabetes raises risk, which suggests that inherited biology and shared environment both play a role 1, 3.

Age-related changes in body composition and metabolism

Risk rises with age, especially from age 35 onward in diabetes screening guidance. Aging can bring less muscle, more central fat, less activity, and other health changes that make insulin resistance more likely 3.

Smoking and secondhand smoke exposure

Smoking is linked with higher type 2 diabetes risk, and secondhand smoke exposure is also a concern. Quitting smoking supports heart, lung, and metabolic health 1, 9.

Which health conditions can raise the risk of insulin resistance?

Prediabetes and type 2 diabetes are closely tied to insulin resistance, but several other conditions can raise risk too. These include PCOS, sleep apnea, Cushing’s syndrome, acromegaly, gestational diabetes history, metabolic syndrome, and fatty liver disease 1, 3.

  • PCOS can involve insulin resistance even in people who are not overweight. If irregular periods, acne, excess hair growth, or fertility concerns are present, testing should be individualized 1.
  • Sleep apnea is linked with insulin resistance and type 2 diabetes risk. Treating sleep apnea may help overall cardiometabolic health 1, 3.
  • Cushing’s syndrome and glucocorticoid exposure can raise glucose and worsen insulin sensitivity 1, 7.
  • Acromegaly, a condition involving excess growth hormone, can affect glucose metabolism and raise diabetes risk 1.
  • A history of gestational diabetes raises later type 2 diabetes risk, so follow-up testing matters after pregnancy 3.
  • Metabolic syndrome includes a cluster of high blood pressure, high triglycerides, low HDL cholesterol, high glucose, and large waist size. It signals higher heart and diabetes risk 10.
  • MASLD, also called metabolic dysfunction-associated steatotic liver disease and formerly often called NAFLD or fatty liver disease, is closely linked with insulin resistance 12.

Can medications or hormones cause insulin resistance?

Some medicines can worsen glucose metabolism, but the right answer is not to stop them on your own. The safer step is to ask the prescribing clinician whether monitoring, dose changes, or alternatives are appropriate 1, 7.

Glucocorticoids and steroid medicines

Glucocorticoids, such as prednisone and similar steroid medicines, can raise blood glucose and are a recognized risk factor for insulin resistance or prediabetes. In a human randomized study, glucocorticoid exposure changed fuel metabolism, showing a biologic pathway for these effects 7.

Some antipsychotic medicines

Some antipsychotic medicines are associated with weight gain, higher glucose, and lipid changes. If you take one, glucose and lipid monitoring may be part of safe ongoing care 3.

Some medicines used for HIV

Some HIV medicines can affect glucose and fat metabolism. Because HIV treatment protects long-term health, changes should only be made with the clinician managing that care 1.

Can poor sleep, stress, or shift work contribute to insulin resistance?

Sleep and circadian disruption can affect hormones, appetite, blood pressure, and glucose regulation. The evidence supports sleep as part of metabolic health, but it does not mean one bad night “causes” insulin resistance by itself 5, 6.

In a randomized study of night shift workers, oral melatonin was studied for insulin resistance and blood pressure variability, showing that circadian timing is a measurable metabolic factor 6. A separate human study found that sleep loss and daytime napping changed cortisol and inflammatory markers, which are stress-related pathways, but it did not prove that naps reverse insulin resistance 5.

Stress hormones can raise glucose so the body has fuel during stress. If stress, insomnia, or shift work is ongoing, it is worth discussing sleep apnea screening, work schedule, mental health support, and glucose testing with a clinician 3.

What are the warning signs of insulin resistance?

Many people have no warning signs of insulin resistance or prediabetes. That is why risk-based testing is important, especially if you have a family history, PCOS, prior gestational diabetes, high blood pressure, abnormal lipids, fatty liver disease, or a large waist size 1, 3.

  • Possible high blood sugar symptoms include increased thirst, frequent urination, fatigue, blurry vision, slow-healing cuts, and unexplained weight change 11.
  • Acanthosis nigricans and skin tags can be clues that a clinician may notice during an exam, but they do not confirm insulin resistance alone 1.
  • Urgent symptoms, very high readings, vomiting, confusion, dehydration, pregnancy with high glucose, or known diabetes with concerning symptoms should be addressed promptly by a licensed clinician 11.
  • For a deeper symptom guide, see Chia’s article on signs of insulin resistance.

How do clinicians check for insulin resistance or prediabetes?

Clinicians usually check blood glucose risk, not insulin resistance directly. A1C, fasting blood glucose, and oral glucose tolerance testing can identify prediabetes or diabetes; direct insulin-resistance tests are mostly used in research 1, 3.

Test or checkWhat it looks atHow it is used
A1CAverage blood glucose over about 2 to 3 monthsUsed to screen for and diagnose prediabetes or diabetes; learn more in our A1C blood sugar test guide 3.
Fasting blood glucoseBlood glucose after not eating for at least 8 hoursA common screening test for abnormal glucose regulation 3.
Oral glucose tolerance testHow the body handles a measured glucose drinkOften used in pregnancy and sometimes when other results are unclear 3.
Lipids, blood pressure, waist sizeCardiometabolic risk patternHelps identify metabolic syndrome risk, including high triglycerides, low HDL cholesterol, high blood pressure, and large waist size 10.
Research insulin-sensitivity testsDirect insulin response or glucose disposalMostly used in research, not routine primary care 1.

Can insulin resistance go back to normal?

Insulin sensitivity can improve, but how much depends on the cause, genetics, weight pattern, medicines, sleep, activity, and related conditions. Some people can return blood glucose from prediabetes to the normal range; others need long-term monitoring and treatment 1, 4.

Physical activity is one of the clearest tools because working muscle uses glucose. Both aerobic activity and resistance training can support glucose control, and even small increases in daily movement can help reduce long sitting time 2, 4.

When excess weight is part of the picture, weight loss can improve insulin sensitivity. In a 2026 human study of marked weight loss in type 2 diabetes, weight loss through gastric bypass or low-calorie diet changed post-meal glucose disposal, supporting the link between weight loss and glucose handling; individual results vary 8.

A balanced eating pattern can support steadier blood sugar 2, 4. A practical plate often includes non-starchy vegetables, high-fiber carbohydrates, lean protein, healthy fats, and fewer sugar-sweetened drinks. For more, see our guide to losing weight with insulin resistance and our article on whether prediabetes can be reversed.

Sleep, stress, smoking cessation, and treating sleep apnea may also matter. These steps are not a substitute for diabetes care, but they can lower the load on the metabolic system 3, 6, 9.

Which next step fits which person?

The right next step depends on risk, symptoms, and whether blood glucose is already abnormal. This table is not a diagnosis; it is a way to think about what to ask a clinician next.

Your situationSensible next stepWhy it matters
No symptoms, but family history, PCOS, prior gestational diabetes, high blood pressure, abnormal lipids, or large waist sizeAsk about A1C or fasting glucose screeningInsulin resistance and prediabetes often have no symptoms 1, 3.
Thirst, frequent urination, blurry vision, fatigue, or slow-healing cutsContact a clinician for glucose testingThese can be symptoms of high blood sugar and should not be ignored 11.
Taking steroids, antipsychotic medicines, or HIV medicinesAsk the prescribing clinician about glucose monitoringSome medicines can affect glucose metabolism, but stopping them without guidance can be unsafe 1, 7.
Excess weight is part of the picture and lifestyle steps have not been enoughAsk whether clinician-guided weight-management treatment is appropriateWeight loss can improve insulin sensitivity for some people, but medication choice depends on health history, risks, and goals 4, 8.
Known diabetes, pregnancy, very high readings, vomiting, confusion, or dehydrationSeek prompt medical careThese situations need individualized medical guidance and sometimes urgent care 11.

3-min quiz

Considering weight-management care?

If weight management is part of your insulin-resistance plan, Chia can help you start with an online health questionnaire and review by a licensed US provider. Prescriptions are provided only when clinically appropriate and are never guaranteed. Chia offers compounded semaglutide injection and compounded tirzepatide tablets or injection through state-licensed 503A pharmacies. Compounded drugs are not FDA-approved.

When can weight-loss treatment at Chia fit into an insulin-resistance plan?

Chia may fit when weight management is clinically appropriate, not as a stand-alone “insulin resistance cure.” Our providers review your health history, goals, medicines, and risk factors before deciding whether prescription treatment is appropriate.

Semaglutide is the active ingredient in Ozempic, Wegovy, and Rybelsus; it is a GLP-1 receptor agonist 13, 14. Tirzepatide is the active ingredient in Mounjaro and Zepbound; it is a dual GIP and GLP-1 receptor agonist 15, 16. Chia offers compounded semaglutide via state-licensed 503A pharmacy as an injection, and compounded tirzepatide via state-licensed 503A pharmacy as tablets or injection.

FDA-approved semaglutide labels include gastrointestinal side effects such as nausea, vomiting, diarrhea, constipation, and abdominal pain, plus warnings for risks such as gallbladder disease, pancreatitis, kidney injury from dehydration, and a boxed warning about thyroid C-cell tumors in rodents 13, 14. FDA-approved tirzepatide labels include similar gastrointestinal effects and warnings, including pancreatitis, gallbladder disease, hypoglycemia risk when used with insulin or sulfonylureas, and the same thyroid C-cell tumor boxed warning 15, 16. These label data are for FDA-approved products; outcomes are not established for compounded formulations.

Chia optionForms Chia offersCurrent starting priceHow it may fit
SemaglutideInjection; microdosing plans available when prescribedPlans currently start at $249/moMay fit eligible patients whose provider-guided plan includes GLP-1 weight management. See semaglutide at Chia.
TirzepatideTablets or injection; microdosing plans available when prescribedTablets currently start at $249/mo; injection currently starts at $299/moMay fit eligible patients who prefer a tablet option or an injectable option after provider review. See tirzepatide at Chia.
Weight + EnergyNAD+ injection plus choice of GLP-1Plans currently start at $309/moMay fit eligible patients whose goals include weight management and energy support. NAD+ injection is not FDA-approved for weight loss. See Weight + Energy.
Weight + MuscleSermorelin injection plus choice of GLP-1Plans currently start at $329/moMay fit eligible patients whose plan includes weight management and muscle-support goals. Compounded sermorelin is not FDA-approved. See Weight + Muscle.

Chia care is 100% online: you complete a short health questionnaire, a licensed US provider reviews it, and medication is prescribed only when clinically appropriate. If prescribed, medication is compounded in the US by a state-licensed 503A pharmacy and shipped to your door. Dosing is provider-guided and adjusted over time, and patients can message the care team through the portal.

GLP-1 treatment is not a substitute for diabetes care, blood glucose monitoring, nutrition changes, physical activity, sleep care, or follow-up with your clinician. If you have diabetes, use insulin, take sulfonylureas, are pregnant, or have urgent symptoms, medication decisions need individualized medical guidance.

What should you ask a clinician if you think you have insulin resistance?

Good questions can make the visit more useful. Bring a list of symptoms, family history, medicines, supplements, pregnancy history, sleep concerns, and any home glucose readings.

  1. 1Which blood tests make sense for my risk level: A1C, fasting glucose, oral glucose tolerance test, lipids, liver enzymes, or another test?
  2. 2Could my symptoms be from another condition, such as thyroid disease, anemia, sleep apnea, PCOS, Cushing’s syndrome, acromegaly, or diabetes?
  3. 3Could any of my current medicines affect glucose metabolism?
  4. 4Is weight-loss medication clinically appropriate for me, and what are the side effects or reasons I should not use it?
  5. 5How often should we repeat labs, weight, waist size, blood pressure, or medication check-ins?

When should you get medical help now?

Get help promptly if you have very high glucose readings, severe thirst, frequent urination with dehydration, vomiting, confusion, fainting, chest pain, trouble breathing, pregnancy with high glucose, or known diabetes with worsening symptoms. These can signal a problem that needs urgent medical care 11.

If your concern is not urgent, schedule a clinician visit for testing and a plan. Insulin resistance is common, but it is also actionable when you know what is driving it.

3-min quiz

Start with a clinician-reviewed plan

If your clinician-guided plan includes weight management, Chia can review whether compounded semaglutide injection, compounded tirzepatide tablets or injection, or a GLP-1-based protocol may be appropriate for you. A prescription requires a medical evaluation and is not guaranteed. Compounded drugs are not FDA-approved.

FAQ

References

  1. 1.National Institute of Diabetes and Digestive and Kidney Diseases. Insulin Resistance & Prediabetes. NIDDK, 2024.
  2. 2.Centers for Disease Control and Prevention. About Insulin Resistance and Type 2 Diabetes. CDC, 2024.
  3. 3.American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2026. Diabetes Care, 2026.
  4. 4.Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 2002.
  5. 5.Vgontzas AN, Pejovic S, Zoumakis E, et al. Daytime napping after a night of sleep loss decreases sleepiness, improves performance, and causes beneficial changes in cortisol and interleukin-6 secretion. American Journal of Physiology-Endocrinology and Metabolism, 2007.
  6. 6.Hannemann J, Laing A, Middleton B, et al. Effect of oral melatonin treatment on insulin resistance and diurnal blood pressure variability in night shift workers: a double-blind, randomized, placebo-controlled study. Pharmacological Research, 2024.
  7. 7.Stimson RH, Anderson AJ, Ramage LE, et al. Acute physiological effects of glucocorticoids on fuel metabolism in humans are permissive but not direct. Diabetes, Obesity & Metabolism, 2017.
  8. 8.Mittendorfer B, Patterson BW, Eagon JC, et al. Effects of marked weight loss induced by gastric bypass surgery or low-calorie diet alone on postprandial glucose disposal in type 2 diabetes. Diabetes, 2026.
  9. 9.U.S. Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. 2014.
  10. 10.Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention and other organizations. Circulation, 2009.
  11. 11.Centers for Disease Control and Prevention. Diabetes Symptoms. CDC, 2024.
  12. 12.Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology, 2023.
  13. 13.U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information. FDA, 2024.
  14. 14.U.S. Food and Drug Administration. Ozempic (semaglutide) injection prescribing information. FDA, 2025.
  15. 15.U.S. Food and Drug Administration. Zepbound (tirzepatide) injection prescribing information. FDA, 2025.
  16. 16.U.S. Food and Drug Administration. Mounjaro (tirzepatide) injection prescribing information. FDA, 2025.

About this article

Chia Health Editorial Team — Evidence-reviewed health education

This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.

AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.

Get a personalized plan

See if GLP-1 is right for your body.

Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.

Take the 3-min quiz

Keep reading

Back to all guides